BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6138864)

  • 1. [The role of the sympathomimetic activity of beta-adrenergic blockaders in the treatment of patients with chronic ischemic heart disease].
    Ol'binskaia LI; Bragina GI
    Ter Arkh; 1983; 55(9):35-40. PubMed ID: 6138864
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Bragina GI
    Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of anabolic steroids and adrenergic beta receptor blockaders on the indicators of rheogram of the aorta and lungs in patients with ischemic heart disease].
    Sharlaĭ IR
    Vrach Delo; 1974 Aug; 0(8):15-7. PubMed ID: 4153197
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of the combined use of adrenergic beta receptor blockaders and long-acting nitrates in chronic ischemic heart disease].
    Bragina GI
    Klin Med (Mosk); 1981 Nov; 59(11):36-42. PubMed ID: 6119395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
    Raff U; Jeschke D
    Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest.
    Svendsen TL; Hartling OJ; Trap-Jensen J; McNair A; Bliddal J
    Clin Pharmacol Ther; 1981 Jun; 29(6):711-8. PubMed ID: 6112090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C; Oztürk M
    Presse Med (1893); 1971 Apr; 79(17):765-6. PubMed ID: 4396515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
    Noack E
    MMW Munch Med Wochenschr; 1982 Apr; 124(15):377-80. PubMed ID: 6123078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of beta blockaders in arrhythmias and ischemic heart disease].
    Rosselot E
    Rev Med Chil; 1982 Dec; 110(12):1224-32. PubMed ID: 6135249
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta blockaders and the exercise test].
    Mirto U
    G Clin Med; 1979 May; 60(5):409-18. PubMed ID: 39862
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immediate effect of beta-blockaders on coronary patients during exertion].
    Vastesaeger MM; Rasson G
    Brux Med; 1971 Jun; 51(6):429-36. PubMed ID: 4397872
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacology of nitrites and adrenergic beta blockaders in coronary circulation].
    Méndez R
    Arch Inst Cardiol Mex; 1980; 50(3):283-88. PubMed ID: 6107070
    [No Abstract]   [Full Text] [Related]  

  • 15. [Beta blockaders and their therapeutic use in cardiology].
    Gvozdják J
    Cas Lek Cesk; 1973 Dec; 112(51):1593-4. PubMed ID: 4149039
    [No Abstract]   [Full Text] [Related]  

  • 16. [Functional dynamics of ischemic heart disease patients with stable stenocardia as affected by drug treatment].
    Sidorenko BA; Lupanov VP; Kulikova TV; Nekrutman EA; Matveeva LS
    Klin Med (Mosk); 1984 Nov; 62(11):44-51. PubMed ID: 6151611
    [No Abstract]   [Full Text] [Related]  

  • 17. [Results of clinical studies of beta stimulating agents in the treatment of chronic heart disease].
    Metelutsa VI; Chazova LV; Grigor'iants RA; Krol VA; Trubetskoĭ AV
    Ter Arkh; 1977; 49(4):44-8. PubMed ID: 17171
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
    Kotko DN; Fed'ko GP; Iaroshenko IuT
    Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.